08:38 ETWorld's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical
UBS lowers the target price for SINO BIOPHARM to 11 yuan, rating it as "Buy"